Drug Shortage Report for DOXORUBICIN
Report ID | 40515 |
Drug Identification Number | 02410397 |
Brand name | DOXORUBICIN |
Common or Proper name | Doxorubicin |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | DOXORUBICIN HYDROCHLORIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVESICAL |
Packaging size | 1 x 25mL |
ATC code | L01DB |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-03-13 |
Estimated end date | Unknown |
Actual end date | 2019-05-01 |
Shortage status | Resolved |
Updated date | 2019-05-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v23 | 2019-05-02 | French | Compare |
v22 | 2019-05-02 | English | Compare |
v21 | 2019-02-26 | French | Compare |
v20 | 2019-02-26 | English | Compare |
v19 | 2019-01-16 | French | Compare |
v18 | 2019-01-16 | English | Compare |
v17 | 2018-12-17 | French | Compare |
v16 | 2018-12-17 | English | Compare |
v15 | 2018-10-23 | French | Compare |
v14 | 2018-10-23 | English | Compare |
v13 | 2018-09-26 | French | Compare |
v12 | 2018-09-26 | English | Compare |
v11 | 2018-06-08 | French | Compare |
v10 | 2018-06-08 | English | Compare |
v9 | 2018-05-29 | French | Compare |
v8 | 2018-05-29 | English | Compare |
v7 | 2018-04-02 | French | Compare |
v6 | 2018-04-02 | English | Compare |
v5 | 2018-03-22 | French | Compare |
v4 | 2018-03-22 | English | Compare |